Devasted1 said...
I had two Provenge Treatments in March, 2010 and the third treatment in April, 2010. I was randomly selected for a fourth treatment which I received n July, 2010 (post RRP).
My last recent PSA test came up with non-detectable. What a miracle, for a Gleason 9, stage 4 can be and is non-detectable after four years.
Go Provenge.
Not a member of either club yet but had a question your post prompted me to ask.
I got the impression from Todd's blog that Provenge is normally 3 strikes and you are out, poor wording I mean that I understood that normally there are only 3 treatments whcih hopefully favorably affect any subsequent treatments with something else.
Also saw this topic today which is on point about
order of treatments needs to be decided.
www.medscape.com/viewarticle/820421?src=wnl_edit_tpal&uac=206170AZIt also mentions another drug in the pipeline "Tasquinimod"
"Currently approved options include sipuleucel-T [3,4] and abiraterone acetate. [5-7] Another drug, enzalutamide, [8] is approved after chemotherapy, but recent studies during the prechemo period have demonstrated a statistically significant benefit. One can expect that the US Food and Drug Administration will eventually give prechemo approval for that drug as well. Tasquinimod, an investigational drug, works by a different method of action from the 3 previously mentioned drugs. [9] Tasquinimod also has shown considerable promise in early studies, and we are awaiting the results from the phase 3 trials.
en.wikipedia.org/wiki/TasquinimodAnother review of various treatment and the difficulty of deciding which order
www.medscape.com/viewarticle/819261?src=wnl_edit_tpal&uac=206170AZLupronJim